Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)

安徽智飞龙科马生物制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 5bde397f6df05a46
Approval Number: 国药准字S20237004
Generic Name: 重组结核杆菌融合蛋白(EC)
Generic Name En: Recombinant Mycobacterium Tuberculosis Fusion Protein(EC)
Trade Name: 宜卡
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每支0.1ml。每1次人用剂量为0.1ml，含5U重组结核杆菌融合蛋白(EC)。
Reg Date: 2023-03-13
Company Name: 安徽智飞龙科马生物制药有限公司
Company Address: 安徽省合肥市高新区明珠大道5008号
Production Company Name: 安徽智飞龙科马生物制药有限公司
Production Company Address: 合肥市高新区浮山路100号
Company Detail Path: /organization/an-hui-zhi-fei-long-ke-ma-sheng-wu-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/an-hui-zhi-fei-long-ke-ma-sheng-wu-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 13, 2023

Approval ID

5bde397f6df05a46

Type

生物制品